326 related articles for article (PubMed ID: 37450126)
1. Liquid Biopsy in Coronary Heart Disease.
Zhu W; Li X
Methods Mol Biol; 2023; 2695():279-293. PubMed ID: 37450126
[TBL] [Abstract][Full Text] [Related]
2. Fluid-based assays and precision medicine of cardiovascular diseases: the 'hope' for Pandora's box?
Benincasa G; Mansueto G; Napoli C
J Clin Pathol; 2019 Dec; 72(12):785-799. PubMed ID: 31611285
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy in CNS tumors: Current status & future perspectives.
Husain N; Husain A; Mishra S; Srivastava P
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
5. Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer.
Chen H; Xu C; Fang Z; Mao S
Methods Mol Biol; 2023; 2695():165-179. PubMed ID: 37450118
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
[TBL] [Abstract][Full Text] [Related]
7. Circulating miR-30c as a predictive biomarker of type 2 diabetes mellitus with coronary heart disease by regulating PAI-1/VN interactions.
Luo M; Wang G; Xu C; Zeng M; Lin F; Wu J; Wan Q
Life Sci; 2019 Dec; 239():117092. PubMed ID: 31760103
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy in Neurological Diseases.
Malhotra S; Miras MCM; Pappolla A; Montalban X; Comabella M
Cells; 2023 Jul; 12(14):. PubMed ID: 37508574
[TBL] [Abstract][Full Text] [Related]
9. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
10. The Value of Cell-Free Circulating DNA Profiling in Patients with Skin Diseases.
Ma J; Teng Y; Youming H; Tao X; Fan Y
Methods Mol Biol; 2023; 2695():247-262. PubMed ID: 37450124
[TBL] [Abstract][Full Text] [Related]
11. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
[No Abstract] [Full Text] [Related]
12. Liquid Biopsy for Promising Non-invasive Diagnostic Biomarkers in Parasitic Infections.
Ozturk EA; Caner A
Acta Parasitol; 2022 Mar; 67(1):1-17. PubMed ID: 34176040
[TBL] [Abstract][Full Text] [Related]
13. Cell-Free DNA: Applications in Different Diseases.
Ranucci R
Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNA profiles based on direct S-Poly(T)Plus assay for detection of coronary heart disease.
Su M; Niu Y; Dang Q; Qu J; Zhu D; Tang Z; Gou D
J Cell Mol Med; 2020 Jun; 24(11):5984-5997. PubMed ID: 32343493
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.
Kong W; Chen T; Li Y
Methods Mol Biol; 2023; 2695():127-143. PubMed ID: 37450116
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
18. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
19. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs.
Casagrande GMS; Silva MO; Reis RM; Leal LF
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768828
[TBL] [Abstract][Full Text] [Related]
20. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
